Prescription medication borrowing and sharing among women of reproductive age.
ABSTRACT The purpose of this study was to describe the patterns of prescription medication borrowing and sharing among adults, particularly women of reproductive age.
Data were collected from the 2001-2006 HealthStyles surveys, an annual mail survey conducted in the United States concerning trends in health behavior. The total responses received were 26,566 of 36,420 surveys mailed (response rate 73%). Of these total responses, there were 7,456 women of reproductive age (18-44 years). Survey questions included whether participants had ever shared or borrowed a prescription medication, how often participants shared or borrowed medications in the past year, and types of medications shared or borrowed. Data were weighted by matching sex, age, income, race, and household size variables to annual U.S. census data. Associations between demographic factors and borrowing and sharing were studied.
Overall, 28.8% of women and 26.5% of men reported ever borrowing or sharing prescription medications. Women of reproductive age were more likely to report prescription medication borrowing or sharing (36.5%) than women of nonreproductive age (>or=45 years) (19.5%) (rate ratio [RR] 1.87, 95% confidence interval [CI] 1.77-1.99). Of reproductive-aged women who borrowed or shared prescription medication, the most common medications borrowed or shared were allergy medications (43.8%) and pain medications (42.6%).
Prescription medication borrowing and sharing is a common behavior among adults and is more common among reproductive-aged women than among women in other age groups.
Pharmacoepidemiology and Drug Safety 02/2015; 24(2):218-20. DOI:10.1002/pds.3742 · 3.17 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Background The practice of medication sharing, the lending (giving) or borrowing (taking) of prescription medicines, has been reported increasingly in the literature. Aim This study aimed to investigate prescription medication sharing practices among adults in Auckland, New Zealand. Setting Community pharmacies in Auckland. Method A cross-sectional survey was conducted in ten community pharmacies in Auckland during March, 2012. Clients were invited to complete an anonymous questionnaire to assess their medication sharing practices. Main outcome measures Proportion of respondents reporting lending or borrowing; information provided or received. Results Of all participants (N = 642), 25.5 % reported borrowing, and 24.1 % reported lending prescribed medicines in the past year. Furthermore, 14.8 % of participants reported ever giving a child's prescribed medicine to another child in their care, and 49.8 % reported having leftover prescription medicines at home. Of those who borrowed medicines (n = 164), 56.1 % received written medication instructions from the lender, and of the lenders (n = 155), 47.1 % provided verbal instructions with the lent medicines. Conclusion The sharing of prescription medicines in Auckland appears to be similar to that reported in other developed countries, and it is now clear that information provision while sharing does not always occur. Approaches to reduce harm resulting from sharing medicines should be explored.International Journal of Clinical Pharmacy 11/2014; 36(6). DOI:10.1007/s11096-014-0031-x · 1.25 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Background: Although many medications have documented teratogenic effects, there are relatively little population-based data on perinatal prescription drug use. Methods: Hawaii Pregnancy Risk Assessment Monitoring System (PRAMS) data from 3180 respondents were used to estimate prevalence of overall prescription drug use during and in the month before pregnancy. Data were weighted to be representative of all pregnancies resulting in live births in Hawaii in 2009 and 2010. Vitamins and supplements were excluded from the analysis. Results: Of recently-pregnant women in Hawaii, 18.3% (95%CI: 16.6-20.1) reported using prescription drugs during their most recent pregnancy; 14.5% reported prescription use immediately before pregnancy (95%CI: 13.0-16.1). The most commonly-reported medication types taken during pregnancy were anti-infectives (4.2%; 95%CI: 3.4-5.1), asthma/allergy (3.4%; 95%CI: 2.7-4.3), gastrointestinal (3.3%; 95%CI: 2.5-4.2) and pain relievers (3.2%; 95%CI: 2.5-4.2). Pain relievers (2.8%; 95%CI: 2.2-3.7), asthma/allergy (2.8%; 95%CI: 2.2-3.6), anti-infectives (2.3%; 95%CI: 1.7-3.1) and psychiatric medications (2.2%; 95%CI: 1.6-2.9) were most common before pregnancy. Of women reporting prescription use during pregnancy, 10.0% reported that their healthcare provider had not counseled them during prenatal care on which medicines are safe to use during pregnancy (95%CI: 7.3-13.5). Public Health Implications: As prescription drug use among the general public becomes more widespread, there is an increased need for careful monitoring by health care providers of usage in pregnant and reproductive-aged women. Counseling on potential risks to mother and fetus should be emphasized during prenatal care visits to assure that women are informed and empowered to make the best decisions for themselves and their babies.140st APHA Annual Meeting and Exposition 2012; 10/2012